The Global Market for Veterinary Dermatology Drugs Market is expected to boost at an annual rate of 9.6% between 2021 and 2028 and accounted for US$ 7.8 Billion in 2020.

Dermatology problems are highly common in dogs, and they are the second most common reason they are taken to the veterinarian. Because skin and fur are markers of dogs' and cats' overall health, every pet owner is aware of skin illnesses. Dogs, like people, can develop a range of skin diseases as a result of their environment or heredity. Skin allergies, bacterial infections, insect bites, hot spots, rashes, impetigo, mange, and dermatitis are all common problems seen by veterinarians. Skin disorders account for more than ten percent of all diseases seen in pets. Allergies can be seasonal, triggered by airborne particles like pollen, mould, or dander, or environmental, handed down genetically. Both will induce skin inflammation and itching. Medication or immunotherapy can be used to treat them. Any protrusion, lump, bump, or foreign growth on the dog's skin qualifies. It could be a benign cyst or lump, or it could be a dangerous tumor that requires removal and additional cancer treatments in the worst-case scenario. Cats, too, can develop a variety of skin disorders as a result of infections, bugs, or allergies. Itching, dry or flaky skin and over-grooming are the most prevalent symptoms. A veterinarian will be able to determine the source of the problem and begin therapy.

Veterinary Dermatology Drugs Market Dynamics

Increasing expenditure on veterinary health care is expected to drive the market at a significant rate. More pets, more pet parents going to the vet, and a rise in vet expenditures due to labor and more modern treatments for vets drawn from human medicine are all putting a strain on the wallet. The cost of veterinary treatment has increased due to rising medicine and pharmaceutical prices, as well as the expense of new technology and medical equipment. The increased spending reflects not only higher costs but also a number of other reasons, such as a growth in the number of pets and longer pet lifespans, which necessitates more veterinarian care.

However, limited awareness in emerging countries may constrain market growth. Furthermore, the surge in prevalence of chronic skin diseases such as chewing, biting, and rubbing is likely to create numerous growth opportunities for the market in the coming years. Atopic dermatitis is an allergic skin disorder caused by harmless items such as grass, house dust mites, mould spores, and other allergens in the environment.

Veterinary Dermatology Drugs Market Segmentation

Animal type, route of administration, indication, distribution channel, and regions are the segmentations of the global veterinary dermatology drugs market. Livestock animals and companion animals are the two sorts of animals classified by the market. Topical, oral, and other routes of administration are all segmented. There are three types of indications: allergy illnesses, parasitic infections, and others. The distribution channel section includes e-commerce, retail, and hospital pharmacies.

Veterinary Dermatology Drugs Regional Stance

Based on regions, the global veterinary dermatology drugs industry is segmented into North America, Asia-Pacific, Latin America, Europe, and the Middle East & Africa. Among them, North America conquered the largest market share in 2020. The high adoption rate of pets in countries such as the US and Canada is the primary reason for the regional expansion. Every year, around 6.3 million companion animals are surrendered to animal shelters across the US. There are around 3.2 million cats and 3.1 million dogs among them. According to the American Pet Products Association, the country's pet population is expected to be 78 million dogs and 85.8 million cats. In the United States, around 44% of all homes have a dog, and 35% have a cat. Furthermore, the Asia-Pacific region is expected to attain the fastest growth rate during the predicted period 2021 – 2028. Increasing awareness among pet parents and growing veterinary hospitals in countries such as China and India are expected to surge the demand for APAC veterinary dermatology drugs market.

Global Veterinary Dermatology Drugs Segment Analysis

Market By Animal Type

·         Livestock Animal

·         Companion Animal

Market By Route of Administration

·         Topical

·         Oral

·         Injectable

Market By Indication

·         Allergic Infections

·         Parasitic Infections

·         Others

Market By Distribution Channel

·         E-Commerce

·         Retail

·         Hospital Pharmacies

Competitive Landscape

This section of the report identifies the market's major players. Bimeda, Inc., Ceva, Elanco Animal Health, Vetoquinol SA, Intervet Inc., a subsidiary of Merck & Co. Inc., Virbac, Zoetis, Vivaldis are the key companies mentioned in the research.

Veterinary Dermatology Drugs Market Regional Overview

North America

·         U.S.

·         Canada

Europe

·         U.K.

·         Germany

·         France

·         Spain

·         Rest of Europe

Latin America

·         Brazil

·         Mexico

·         Rest of Latin America

Asia-Pacific

·         China

·         Japan

·         India

·         Australia

·         South Korea

·         Rest of Asia-Pacific

Middle East & Africa

·         GCC

·         South Africa

·         Rest of Middle East & Africa